Mefruside

Mefruside
	File:Mefruside.png
Systematic (IUPAC) name
	4-chloro-N1-methyl-N1-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
Clinical data
Routes of; administration	Oral
Legal status
Legal status	℞ (Prescription only);
Identifiers
CAS Number	7195-27-9
ATC code	C03BA05 (WHO)
PubChem	CID 4047
Chemical data
Formula	C13H19ClN2O5S2
Molar mass	382.88 g/mol[[Script error: No such module "String".]]
	Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.^[1]

It was developed by Bayer A.G. and is sold under the tradename Baycaron.

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

30px	This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. v d e

↑ Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.

Systematic (IUPAC) name
File:Mefruside.png
4-chloro-N¹-methyl-N¹-[(2-methyltetrahydrofuran-2-yl)methyl]benzene-1,3-disulfonamide
Clinical data
Routes of administration	Oral
Legal status
Legal status	℞ (Prescription only)
Identifiers
CAS Number	7195-27-9
ATC code	C03BA05 (WHO)
PubChem	CID 4047
Chemical data
Formula	C₁₃H₁₉ClN₂O₅S₂
Molar mass	382.88 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".